筛选出 59 条数据

    品牌 产品 货期 价格 货号 规格 /
    代谢1186486-62-3

    CAS号:1186486-62-3

    品名:Evacetrapib;反式-4-[[(5S)-5-[[[3,5-双(三氟甲基)苯基]甲基](2-甲基-2H-四氮唑-5-基)氨基]-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基]甲基]环己烷羧酸Evacetrapib

    中文别名:反式-4-[[(5S)-5-[[[3,5-双(三氟甲基)苯基]甲基](2-甲基-2H-四氮唑-5-基)氨基]-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基]甲基]环己烷羧酸;

    英文别名:LY2484595;trans-4-[[(5S)-5-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylicacid;4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylicacid;

    分子式:C31H36F6N6O2

    分子量:638.647

    精确质量:638.28

    Psa:87.38

    UNII号:51XWV9K850

    密度:1.40

    简介:EvacetrapibwasadrugunderdevelopmentbyEliLilly&Company(investigationalnameLY2484595)thatinhibitscholesterylestertransferprotein(CETP),whichtransfersandtherebyincreaseshigh-densitylipoproteinandlowerslow-densitylipoprotein(CETPinhibitor].Itisthoughtthatmodifyinglipoproteinlevelsmodifiestheriskofcardiovasculardisease.ThefirstCETPinhibitor,torcetrapib,wasunsuccessfulbecauseitincreasedlevelsofthehormonealdosteroneandincreasedbloodpressure,whichledtoexcesscardiaceventswhenitwasstudied.Evacetrapibdoesnothavethesameeffect.WhenstudiedinasmallclinicaltrialinpeoplewithelevatedLDLandlowHDL,significantimprovementswerenotedintheirlipidprofile.

     1186486-62-3 详细信息

    代谢

    CAS号:1186486-62-3

    品名:Evacetrapib;反式-4-[[(5S)-5-[[[3,5-双(三氟甲基)苯基]甲基](2-甲基-2H-四氮唑-5-基)氨基]-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基]甲基]环己烷羧酸Evacetrapib

    中文别名:反式-4-[[(5S)-5-[[[3,5-双(三氟甲基)苯基]甲基](2-甲基-2H-四氮唑-5-基)氨基]-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基]甲基]环己烷羧酸;

    英文别名:LY2484595;trans-4-[[(5S)-5-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylicacid;4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylicacid;

    分子式:C31H36F6N6O2

    分子量:638.647

    精确质量:638.28

    Psa:87.38

    UNII号:51XWV9K850

    密度:1.40

    简介:EvacetrapibwasadrugunderdevelopmentbyEliLilly&Company(investigationalnameLY2484595)thatinhibitscholesterylestertransferprotein(CETP),whichtransfersandtherebyincreaseshigh-densitylipoproteinandlowerslow-densitylipoprotein(CETPinhibitor].Itisthoughtthatmodifyinglipoproteinlevelsmodifiestheriskofcardiovasculardisease.ThefirstCETPinhibitor,torcetrapib,wasunsuccessfulbecauseitincreasedlevelsofthehormonealdosteroneandincreasedbloodpressure,whichledtoexcesscardiaceventswhenitwasstudied.Evacetrapibdoesnothavethesameeffect.WhenstudiedinasmallclinicaltrialinpeoplewithelevatedLDLandlowHDL,significantimprovementswerenotedintheirlipidprofile.

    展开

    代谢1186486-62-3
    TargetMol 化合物Evacetrapib Evacetrapi 现货

     678.00
    T6262 98.53%
    代谢801312-28-7

    CAS号:801312-28-7

    品名:6-[[3-[(二甲基氨基)羰基]苯基]磺酰]-4-[(3-甲氧基苯基)氨基]-8-甲基-3-喹啉甲酰胺6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide

    中文别名:6-[[3-[(二甲基氨基)羰基]苯基]磺酰基]-4-[(3-甲氧基苯基)氨基]-8-甲基-3-喹啉羧酰胺;

    英文别名:6-[[3-[(DIMETHYLAMINO)CARBONYL]PHENYL]SULFONYL]-4-[(3-METHOXYPHENYL)AMINO]-8-METHYL-3-QUINOLINECARBOXAMIDE;3gwt;

    分子式:C27H26N4O5S

    分子量:518.584

    精确质量:518.162

    Psa:144.29

    MDL号:MFCD18206923

    密度:1.345

    沸点:791.685ºC at 760 mmHg

    闪点:432.596ºC

    简介:QuinolinederivativeandapotentialselectivePDE4phosphodiesteraseinhibitortotreatprophylaxisortreatmentofclinicalconditionssuchasinflammatoryorallergicdiseases.

     801312-28-7 详细信息

    代谢

    CAS号:801312-28-7

    品名:6-[[3-[(二甲基氨基)羰基]苯基]磺酰]-4-[(3-甲氧基苯基)氨基]-8-甲基-3-喹啉甲酰胺6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide

    中文别名:6-[[3-[(二甲基氨基)羰基]苯基]磺酰基]-4-[(3-甲氧基苯基)氨基]-8-甲基-3-喹啉羧酰胺;

    英文别名:6-[[3-[(DIMETHYLAMINO)CARBONYL]PHENYL]SULFONYL]-4-[(3-METHOXYPHENYL)AMINO]-8-METHYL-3-QUINOLINECARBOXAMIDE;3gwt;

    分子式:C27H26N4O5S

    分子量:518.584

    精确质量:518.162

    Psa:144.29

    MDL号:MFCD18206923

    密度:1.345

    沸点:791.685ºC at 760 mmHg

    闪点:432.596ºC

    简介:QuinolinederivativeandapotentialselectivePDE4phosphodiesteraseinhibitortotreatprophylaxisortreatmentofclinicalconditionssuchasinflammatoryorallergicdiseases.

    展开

    代谢801312-28-7
    TargetMol 化合物GSK256066 GSK256066 现货

     679.00
    T6054 99.66%
    代谢940908-79-2

    CAS号:940908-79-2

    品名:Mericitabine

    中文别名:Mericitabine

    英文别名:CS-0596;Mericitabine(USAN/INN);RG7128;Mericitabine;R-7128;

    分子式:C18H26FN3O6

    分子量:399.414

    精确质量:399.181

    Psa:122.74

    UNII号:TA63JX8X52

    密度:

    储存条件:2-8℃

     940908-79-2 详细信息

    代谢

    CAS号:940908-79-2

    品名:Mericitabine

    中文别名:Mericitabine

    英文别名:CS-0596;Mericitabine(USAN/INN);RG7128;Mericitabine;R-7128;

    分子式:C18H26FN3O6

    分子量:399.414

    精确质量:399.181

    Psa:122.74

    UNII号:TA63JX8X52

    密度:

    储存条件:2-8℃

    展开

    代谢940908-79-2
    源叶 R-7128 R-7128 现货

     990.00
    T29097 10mMinDMSO
    代谢923604-59-5

    CAS号:923604-59-5

    品名:司美匹韦Simeprevir

    中文别名:(2R,3aR,10Z,11aS,12aR,14aR)-N-(环丙基磺酰基)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-十四氢-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[c]环丙并[g][1,6]二氮杂环十四烯-12a(1H)-甲酰胺;

    英文别名:Olysio(TN);(2R,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide;TMC435;TMC-435350;TMC435350;

    分子式:C38H47N5O7S2

    分子量:749.939

    精确质量:749.292

    Psa:193.51

    UNII号:9WS5RD66HZ

    密度:1.38

    简介:Simeprevir(formerlyTMC435;tradenamesOlysioandSovriad)isadrugforthetreatmentandcureofhepatitisC.ItwasdevelopedbyMedivirandJohnson&Johnson'spharmaceuticaldivisionJanssenPharmaceutica.IntheUnitedStates,simeprevirisapprovedbytheFoodandDrugAdministrationforuseincombinationwithpeginterferon-alfaandribavirinforhepatitisC.SimeprevirhasbeenapprovedinJapanforthetreatmentofchronichepatitisCinfection,genotype1.

     923604-59-5 详细信息

    代谢

    CAS号:923604-59-5

    品名:司美匹韦Simeprevir

    中文别名:(2R,3aR,10Z,11aS,12aR,14aR)-N-(环丙基磺酰基)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-十四氢-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[c]环丙并[g][1,6]二氮杂环十四烯-12a(1H)-甲酰胺;

    英文别名:Olysio(TN);(2R,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide;TMC435;TMC-435350;TMC435350;

    分子式:C38H47N5O7S2

    分子量:749.939

    精确质量:749.292

    Psa:193.51

    UNII号:9WS5RD66HZ

    密度:1.38

    简介:Simeprevir(formerlyTMC435;tradenamesOlysioandSovriad)isadrugforthetreatmentandcureofhepatitisC.ItwasdevelopedbyMedivirandJohnson&Johnson'spharmaceuticaldivisionJanssenPharmaceutica.IntheUnitedStates,simeprevirisapprovedbytheFoodandDrugAdministrationforuseincombinationwithpeginterferon-alfaandribavirinforhepatitisC.SimeprevirhasbeenapprovedinJapanforthetreatmentofchronichepatitisCinfection,genotype1.

    展开

    代谢923604-59-5
    阿拉丁 Simeprevir Simeprevi 现货

     720.90
    S426939 Moligand™,10mMinDMSO
    源叶 Simeprevir Simeprevi 现货

     720.00
    T94592 10mMinDMSO
    代谢171596-29-5

    CAS号:171596-29-5

    品名:他达那非Tildenafil

    中文别名:西力士;他地那非;

    英文别名:Cialis;(6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12atetrahydropyrazino[1',2':1,6]pyrido[3,4b]indole1,4(6H,7H)-dione;(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]\r\npyrido[3,4-b]indole-1,4-dione;

    分子式:C22H19N3O4

    分子量:389.404

    精确质量:389.138

    Psa:74.87

    MDL号:MFCD07771966

    外观与性状:灰白色水晶般的固体

    密度:1.51 g/cm3

    沸点:679.1ºC at 760 mmHg

    熔点:298-300ºC

    闪点:364.5ºC

    折射率:1.705

    蒸汽压:5.29E-13mmHg at 25°C

    简介:TadalafilisaPDE5inhibitormarketedinpillformfortreatingerectiledysfunction(ED)underthenameCialis,andunderthenameAdcircaforthetreatmentofpulmonaryarterialhypertension.InOctober2011theU.S.FoodandDrugAdministration(FDA)approvedCialisfortreatingthesignsandsymptomsofbenignprostatichyperplasia(BPH)aswellasacombinationofBPHanderectiledysfunction(ED)whentheconditionscoincide.ItinitiallywasdevelopedbythebiotechnologycompanyICOS,andthenagaindevelopedandmarketedworld-widebyLillyICOS,LLC,thejointventureofICOSCorporationandEliLillyandCompany.Cialistablets,in2.5mg,5mg,10mg,and20mgdoses,areyellow,film-coated,andalmond-shaped.Theapproveddoseforpulmonaryarterialhypertensionis40mg(two20-mgtablets)oncedaily.

    用途:磷酸二酯酶5抑制剂,用于治疗男性勃起功能障碍。

     171596-29-5 详细信息

    代谢

    CAS号:171596-29-5

    品名:他达那非Tildenafil

    中文别名:西力士;他地那非;

    英文别名:Cialis;(6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12atetrahydropyrazino[1',2':1,6]pyrido[3,4b]indole1,4(6H,7H)-dione;(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]\r\npyrido[3,4-b]indole-1,4-dione;

    分子式:C22H19N3O4

    分子量:389.404

    精确质量:389.138

    Psa:74.87

    MDL号:MFCD07771966

    外观与性状:灰白色水晶般的固体

    密度:1.51 g/cm3

    沸点:679.1ºC at 760 mmHg

    熔点:298-300ºC

    闪点:364.5ºC

    折射率:1.705

    蒸汽压:5.29E-13mmHg at 25°C

    简介:TadalafilisaPDE5inhibitormarketedinpillformfortreatingerectiledysfunction(ED)underthenameCialis,andunderthenameAdcircaforthetreatmentofpulmonaryarterialhypertension.InOctober2011theU.S.FoodandDrugAdministration(FDA)approvedCialisfortreatingthesignsandsymptomsofbenignprostatichyperplasia(BPH)aswellasacombinationofBPHanderectiledysfunction(ED)whentheconditionscoincide.ItinitiallywasdevelopedbythebiotechnologycompanyICOS,andthenagaindevelopedandmarketedworld-widebyLillyICOS,LLC,thejointventureofICOSCorporationandEliLillyandCompany.Cialistablets,in2.5mg,5mg,10mg,and20mgdoses,areyellow,film-coated,andalmond-shaped.Theapproveddoseforpulmonaryarterialhypertensionis40mg(two20-mgtablets)oncedaily.

    用途:磷酸二酯酶5抑制剂,用于治疗男性勃起功能障碍。

    展开

    代谢171596-29-5
    源叶 西力士 Tadalafil(IC351) 现货

     741.00
    T93525 10mMinDMSO
    阿拉丁 西力士 Tadalafil(IC351) 现货

     741.90
    T407959 Moligand™,10mMinDMSO
    代谢192185-72-1

    CAS号:192185-72-1

    品名:替吡法尼6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one

    中文别名:(R)-6-(氨基(4-氯苯基)(1-甲基-1H-咪唑-5-基)甲基)-4-(3-氯苯基)-1-甲基-2(1H)-喹啉酮;

    英文别名:Tipifarnib(Zarnestra);Zarnestra;Tipifarnib;

    分子式:C27H22Cl2N4O

    分子量:489.396

    精确质量:488.117

    Psa:65.84

    UNII号:MAT637500A

    外观与性状:灰白色至淡米色固体

    密度:1.33g/cm3

    沸点:681.7ºC at 760mmHg

    熔点:211-213ºC (dec.)

    闪点:366.1ºC

    折射率:1.671

    蒸汽压:1.94E-18mmHg at 25°C

    简介:Afarnesyltransferaseinhibitor.Sensitizeshumanmultiplemyelomacelltoproteasomeinhibitionbyblockingdegradationofbortezomib(B675700)-inducedaggresomes.Alsoshowntoinhibitthegrowthofmyeloidleukemiacelllinesandprimaryleukemiacellsbyinducingapoptosisandcell-cycleblockagewhencombinedwithrapamycin(R124000).

     192185-72-1 详细信息

    代谢

    CAS号:192185-72-1

    品名:替吡法尼6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one

    中文别名:(R)-6-(氨基(4-氯苯基)(1-甲基-1H-咪唑-5-基)甲基)-4-(3-氯苯基)-1-甲基-2(1H)-喹啉酮;

    英文别名:Tipifarnib(Zarnestra);Zarnestra;Tipifarnib;

    分子式:C27H22Cl2N4O

    分子量:489.396

    精确质量:488.117

    Psa:65.84

    UNII号:MAT637500A

    外观与性状:灰白色至淡米色固体

    密度:1.33g/cm3

    沸点:681.7ºC at 760mmHg

    熔点:211-213ºC (dec.)

    闪点:366.1ºC

    折射率:1.671

    蒸汽压:1.94E-18mmHg at 25°C

    简介:Afarnesyltransferaseinhibitor.Sensitizeshumanmultiplemyelomacelltoproteasomeinhibitionbyblockingdegradationofbortezomib(B675700)-inducedaggresomes.Alsoshowntoinhibitthegrowthofmyeloidleukemiacelllinesandprimaryleukemiacellsbyinducingapoptosisandcell-cycleblockagewhencombinedwithrapamycin(R124000).

    展开

    代谢192185-72-1
    阿拉丁 提法法尼 Tipifarnib(R115777) 现货

     880.90
    T408618 Moligand™,10mMinDMSO
    代谢918633-87-1

    CAS号:918633-87-1

    品名:TH302;N,N'-双(2-溴乙基)二氨基膦酸(1-甲基-2-硝基-1H-咪唑-5-基)甲酯2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine

    中文别名:TH302;N,N'-双(2-溴乙基)二氨基膦酸(1-甲基-2-硝基-1H-咪唑-5-基)甲酯

    英文别名:UNII-8A9RZ3HN8W;HAP-302;TH-302;

    分子式:C9H16Br2N5O4P

    分子量:449.036

    精确质量:446.931

    Psa:123.81

    UNII号:8A9RZ3HN8W

    密度:2.0±0.1g/cm3

    沸点:565.4±60.0°Cat760mmHg

    闪点:295.7±32.9°C

    折射率:1.662

    储存条件:-20℃

    蒸汽压:0.0±1.5mmHgat25°C

    简介:Evofosfamide(INN,USAN;formerlyknownasTH-302)isaninvestigationalhypoxia-activatedprodrugthatisinclinicaldevelopmentforcancertreatment.Theprodrugisactivatedonlyatverylowlevelsofoxygen(hypoxia).Suchlevelsarecommoninhumansolidtumors,aphenomenonknownastumorhypoxia.

     918633-87-1 详细信息

    代谢

    CAS号:918633-87-1

    品名:TH302;N,N'-双(2-溴乙基)二氨基膦酸(1-甲基-2-硝基-1H-咪唑-5-基)甲酯2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine

    中文别名:TH302;N,N'-双(2-溴乙基)二氨基膦酸(1-甲基-2-硝基-1H-咪唑-5-基)甲酯

    英文别名:UNII-8A9RZ3HN8W;HAP-302;TH-302;

    分子式:C9H16Br2N5O4P

    分子量:449.036

    精确质量:446.931

    Psa:123.81

    UNII号:8A9RZ3HN8W

    密度:2.0±0.1g/cm3

    沸点:565.4±60.0°Cat760mmHg

    闪点:295.7±32.9°C

    折射率:1.662

    储存条件:-20℃

    蒸汽压:0.0±1.5mmHgat25°C

    简介:Evofosfamide(INN,USAN;formerlyknownasTH-302)isaninvestigationalhypoxia-activatedprodrugthatisinclinicaldevelopmentforcancertreatment.Theprodrugisactivatedonlyatverylowlevelsofoxygen(hypoxia).Suchlevelsarecommoninhumansolidtumors,aphenomenonknownastumorhypoxia.

    展开

    代谢918633-87-1
    阿拉丁 TH-302 TH-302 期货,请咨询

     720.90
    T426926 Moligand™,10mMinDMSO
    源叶 TH-302 TH-302 现货

     720.00
    T99904 10mMinDMSO
    代谢426219-18-3

    CAS号:426219-18-3

    品名:6-(6,7-二氢-7-羟基-5H-吡咯并[1,2-c]咪唑-7-基)-n-甲基-2-萘羧酰胺6-(7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl)-N-methylnaphthalene-2-carboxamide

    中文别名:6-(6,7-二氢-7-羟基-5H-吡咯并[1,2-c]咪唑-7-基)-n-甲基-2-萘羧酰胺

    英文别名:TAK700;(S)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-e]imidazol-7-yl)-N-methyl-2-naphthamide;TAK-700(Orteronel);6-[7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide;Orteronel;

    分子式:C18H17N3O2

    分子量:307.346

    精确质量:307.132

    Psa:67.15

    MDL号:MFCD22200430

    密度:1.4±0.1g/cm3

    沸点:685.1±45.0°Cat760mmHg

    闪点:368.2±28.7°C

    折射率:1.695

    储存条件:-20℃

    蒸汽压:0.0±2.2mmHgat25°C

     426219-18-3 详细信息

    代谢

    CAS号:426219-18-3

    品名:6-(6,7-二氢-7-羟基-5H-吡咯并[1,2-c]咪唑-7-基)-n-甲基-2-萘羧酰胺6-(7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl)-N-methylnaphthalene-2-carboxamide

    中文别名:6-(6,7-二氢-7-羟基-5H-吡咯并[1,2-c]咪唑-7-基)-n-甲基-2-萘羧酰胺

    英文别名:TAK700;(S)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-e]imidazol-7-yl)-N-methyl-2-naphthamide;TAK-700(Orteronel);6-[7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide;Orteronel;

    分子式:C18H17N3O2

    分子量:307.346

    精确质量:307.132

    Psa:67.15

    MDL号:MFCD22200430

    密度:1.4±0.1g/cm3

    沸点:685.1±45.0°Cat760mmHg

    闪点:368.2±28.7°C

    折射率:1.695

    储存条件:-20℃

    蒸汽压:0.0±2.2mmHgat25°C

    展开

    代谢426219-18-3
    TargetMol 化合物(S/R)-Orteronel TAK-700 现货

     913.00
    T6050 97.26%
    代谢348622-88-8

    CAS号:348622-88-8

    品名:UK383367;5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺5-[(3R)-6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl]-1,2,4-oxadiazole-3-carboxamide

    中文别名:UK383367;5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺

    英文别名:CS-0414;

    分子式:C15H24N4O4

    分子量:324.375

    精确质量:324.18

    Psa:134.83

    密度:

     348622-88-8 详细信息

    代谢

    CAS号:348622-88-8

    品名:UK383367;5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺5-[(3R)-6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl]-1,2,4-oxadiazole-3-carboxamide

    中文别名:UK383367;5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺

    英文别名:CS-0414;

    分子式:C15H24N4O4

    分子量:324.375

    精确质量:324.18

    Psa:134.83

    密度:

    展开

    代谢348622-88-8
    阿拉丁 UK383367 UK383367 现货

     720.90
    U423546 10mMinDMSO
    源叶 UK383367 UK383367 现货

     720.00
    T98050 10mMinDMSO
    代谢172732-68-2

    CAS号:172732-68-2

    品名:伐瑞拉迪LY315920(Varespladib)

    中文别名:[[3-(氨基氧代乙酰基)-2-乙基-1-(苯基甲基)-1H-吲哚-4-基]氧基]乙酸;

    英文别名:VARESPLADIB;

    分子式:C21H20N2O5

    分子量:380.394

    精确质量:380.137

    Psa:111.62

    UNII号:2Q3P98DATH

    密度:

    沸点:667.9ºC at 760 mmHg

    闪点:357.7ºC

    蒸汽压:9.53E-19mmHg at 25°C

    简介:ThiscompoundisusedasaPLA2inhibitor(PhospholipaseA2Enzymeinhibitor).

     172732-68-2 详细信息

    代谢

    CAS号:172732-68-2

    品名:伐瑞拉迪LY315920(Varespladib)

    中文别名:[[3-(氨基氧代乙酰基)-2-乙基-1-(苯基甲基)-1H-吲哚-4-基]氧基]乙酸;

    英文别名:VARESPLADIB;

    分子式:C21H20N2O5

    分子量:380.394

    精确质量:380.137

    Psa:111.62

    UNII号:2Q3P98DATH

    密度:

    沸点:667.9ºC at 760 mmHg

    闪点:357.7ºC

    蒸汽压:9.53E-19mmHg at 25°C

    简介:ThiscompoundisusedasaPLA2inhibitor(PhospholipaseA2Enzymeinhibitor).

    展开

    代谢172732-68-2
    源叶 Varespladib(LY315920) Varespladib(LY315920) 现货

     758.00
    T93528 10mMinDMSO
    阿拉丁 Varespladib(LY315920) Varespladib(LY315920) 现货

     758.90
    V407924 Moligand™,10mMinDMSO
    代谢81103-11-9

    CAS号:81103-11-9

    品名:克拉霉素clarithromycin

    中文别名:克拉仙;克拉红霉素;

    英文别名:BIAXIN;Claris;te-03;klacid;Clarithromycin;Veclam;Zeclar;TE-031;Claric;Naxy;Kladd;

    分子式:C38H69NO13

    分子量:747.953

    精确质量:747.477

    Psa:182.91

    RTECS号:KF4997000

    UNII号:H1250JIK0A

    外观与性状:白色至灰白色结晶粉末

    密度:1.18 g/cm3

    沸点:805.5ºC at 760 mmHg

    熔点:217-220ºC

    闪点:440.9ºC

    稳定性:Store in Freezer

    储存条件:Store only in original container. Keep container tightly closed.

    安全说明:S26; S36

    危险类别码:R22

    海关编码:29419000

    危险品标志:Xi; Xn

    简介:Clarithromycin,soldunderthebrandnameBiaxin,isanantibioticusedtotreatvariousbacterialinfections.Thisincludesstrepthroat,pneumonia,skininfections,H.pyloriinfection,andLymedisease,amongothers.Clarithromycincanbetakenbymouthasapillorliquid.

    用途:属大环内酯类抗生素,用于治疗上、下呼吸道感染,皮下软组织感染等。

     81103-11-9 详细信息

    代谢

    CAS号:81103-11-9

    品名:克拉霉素clarithromycin

    中文别名:克拉仙;克拉红霉素;

    英文别名:BIAXIN;Claris;te-03;klacid;Clarithromycin;Veclam;Zeclar;TE-031;Claric;Naxy;Kladd;

    分子式:C38H69NO13

    分子量:747.953

    精确质量:747.477

    Psa:182.91

    RTECS号:KF4997000

    UNII号:H1250JIK0A

    外观与性状:白色至灰白色结晶粉末

    密度:1.18 g/cm3

    沸点:805.5ºC at 760 mmHg

    熔点:217-220ºC

    闪点:440.9ºC

    稳定性:Store in Freezer

    储存条件:Store only in original container. Keep container tightly closed.

    安全说明:S26; S36

    危险类别码:R22

    海关编码:29419000

    危险品标志:Xi; Xn

    简介:Clarithromycin,soldunderthebrandnameBiaxin,isanantibioticusedtotreatvariousbacterialinfections.Thisincludesstrepthroat,pneumonia,skininfections,H.pyloriinfection,andLymedisease,amongothers.Clarithromycincanbetakenbymouthasapillorliquid.

    用途:属大环内酯类抗生素,用于治疗上、下呼吸道感染,皮下软组织感染等。

    展开

    代谢81103-11-9
    Dr.Ehrenstorfer 克拉霉素 Clarithromycin100µg/mLin... 期货,请咨询

     793.00
    A11668540AL-100 100µg/mL
    代谢73963-72-1

    CAS号:73963-72-1

    品名:西洛他唑cilostazol

    中文别名:雷公藤红素;雷公藤红素,南蛇藤素,苦瓜苷;

    英文别名:PLETAAL;RETAL;PLETAL;Cilostal;CILOSTAZOLE;CILASTAZOL;CILOSTAZOLJP;Cilostazol;

    分子式:C20H27N5O2

    分子量:369.461

    精确质量:369.216

    Psa:81.93

    RTECS号:VC8277500

    MDL号:MFCD00866780

    外观与性状:灰白色固体

    密度:1.34 g/cm3

    沸点:664.7ºC at 760 mmHg

    熔点:159-160ºC

    闪点:355.8ºC

    折射率:1.675

    储存条件:Store in original container in a cool dark place.

    WGK Germany:2

    海关编码:2933990090

    危险品标志:Xi

    简介:ApotentphosphodiesteraseIIIA(PDE3A)inhibitor(IC50=0.2uM)andinhibitorofadenosineuptake.Hasantimitogeni,antithrombotic,vasodilatoryandcardiotonicpropertiesinvivo.Alsoaffectslipidlevelsinvivo.

    用途:可抑制血小板聚集,具有抗栓作用。用于治疗慢性动脉闭塞性溃疡、疼痛及冷感等局部性疾病。

     73963-72-1 详细信息

    代谢

    CAS号:73963-72-1

    品名:西洛他唑cilostazol

    中文别名:雷公藤红素;雷公藤红素,南蛇藤素,苦瓜苷;

    英文别名:PLETAAL;RETAL;PLETAL;Cilostal;CILOSTAZOLE;CILASTAZOL;CILOSTAZOLJP;Cilostazol;

    分子式:C20H27N5O2

    分子量:369.461

    精确质量:369.216

    Psa:81.93

    RTECS号:VC8277500

    MDL号:MFCD00866780

    外观与性状:灰白色固体

    密度:1.34 g/cm3

    沸点:664.7ºC at 760 mmHg

    熔点:159-160ºC

    闪点:355.8ºC

    折射率:1.675

    储存条件:Store in original container in a cool dark place.

    WGK Germany:2

    海关编码:2933990090

    危险品标志:Xi

    简介:ApotentphosphodiesteraseIIIA(PDE3A)inhibitor(IC50=0.2uM)andinhibitorofadenosineuptake.Hasantimitogeni,antithrombotic,vasodilatoryandcardiotonicpropertiesinvivo.Alsoaffectslipidlevelsinvivo.

    用途:可抑制血小板聚集,具有抗栓作用。用于治疗慢性动脉闭塞性溃疡、疼痛及冷感等局部性疾病。

    展开

    代谢73963-72-1
    源叶 西洛他唑 Cilostazol(OPC-13013) 现货

     617.00
    T99112 10mMinDMSO
    阿拉丁 西洛他唑 Cilostazol(OPC-13013) 期货,请咨询

     617.90
    C408872 Moligand™,10mMinDMSO
    代谢4991-65-5

    CAS号:4991-65-5

    品名:噻克索酮tioxolone

    中文别名:6-羟基-1,3-苯并噻-2-酮;6-羟基-1,3-苯唑硫醇-2-酮;6-羟基-1,3-苯并噁噻-2-酮;

    英文别名:6-hydroxy-1,3-benzoxathiol-2-one;6-Hydroxy-1,3-benzoxathiol-2-one;6-Hydroxybenzo[d][1,3]oxathiol-2-one;

    分子式:C7H4O3S

    分子量:168.17

    精确质量:167.988

    Psa:78.68

    RTECS号:DM2953750

    UNII号:S0FAJ1R9CD

    外观与性状:淡黄色至米色粉末

    密度:1.617 g/cm3

    沸点:377.8ºC at 760 mmHg

    熔点:158-160°C(lit.)

    折射率:1.718

    稳定性:Stable under normal temperatures and pressures.

    储存条件:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

    安全说明:S26

    危险类别码:R22; R36/37/38

    WGK Germany:3

    海关编码:2930909090

    危险品标志:Xi

    简介:Tioxolone(INN,alsospelledthioxolone)isananti-acnepreparation.

     4991-65-5 详细信息

    代谢

    CAS号:4991-65-5

    品名:噻克索酮tioxolone

    中文别名:6-羟基-1,3-苯并噻-2-酮;6-羟基-1,3-苯唑硫醇-2-酮;6-羟基-1,3-苯并噁噻-2-酮;

    英文别名:6-hydroxy-1,3-benzoxathiol-2-one;6-Hydroxy-1,3-benzoxathiol-2-one;6-Hydroxybenzo[d][1,3]oxathiol-2-one;

    分子式:C7H4O3S

    分子量:168.17

    精确质量:167.988

    Psa:78.68

    RTECS号:DM2953750

    UNII号:S0FAJ1R9CD

    外观与性状:淡黄色至米色粉末

    密度:1.617 g/cm3

    沸点:377.8ºC at 760 mmHg

    熔点:158-160°C(lit.)

    折射率:1.718

    稳定性:Stable under normal temperatures and pressures.

    储存条件:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

    安全说明:S26

    危险类别码:R22; R36/37/38

    WGK Germany:3

    海关编码:2930909090

    危险品标志:Xi

    简介:Tioxolone(INN,alsospelledthioxolone)isananti-acnepreparation.

    展开

    代谢4991-65-5
    TargetMol 噻克索酮 Tioxolone 期货,请咨询

     868.00
    T0515 95.9%
    代谢1432660-47-3

    CAS号:1432660-47-3

    品名:N-环丙基-4-(3-噻吩基)-3-[[[[3-(三氟甲基)苯基]氨基]羰基]氨基]-苯磺酰胺1-[5-(cyclopropylsulfamoyl)-2-thiophen-3-ylphenyl]-3-[3-(trifluoromethyl)phenyl]urea

    中文别名:N-环丙基-4-(3-噻吩基)-3-[[[[3-(三氟甲基)苯基]氨基]羰基]氨基]-苯磺酰胺

    英文别名:FD5013;AGI6780;QCR-283;

    分子式:C21H18F3N3O3S2

    分子量:481.511

    精确质量:481.074

    Psa:127.41

    MDL号:MFCD26097285

    密度:1.5±0.1g/cm3

    折射率:1.652

    储存条件:2~8℃,干燥,密封

    简介:AGI-6780isasmallmoleculeinhibitorofthetumorassociatedmutantIDH2(IsocitrateDehydrogenase-2)inleukemiacells.

     1432660-47-3 详细信息

    代谢

    CAS号:1432660-47-3

    品名:N-环丙基-4-(3-噻吩基)-3-[[[[3-(三氟甲基)苯基]氨基]羰基]氨基]-苯磺酰胺1-[5-(cyclopropylsulfamoyl)-2-thiophen-3-ylphenyl]-3-[3-(trifluoromethyl)phenyl]urea

    中文别名:N-环丙基-4-(3-噻吩基)-3-[[[[3-(三氟甲基)苯基]氨基]羰基]氨基]-苯磺酰胺

    英文别名:FD5013;AGI6780;QCR-283;

    分子式:C21H18F3N3O3S2

    分子量:481.511

    精确质量:481.074

    Psa:127.41

    MDL号:MFCD26097285

    密度:1.5±0.1g/cm3

    折射率:1.652

    储存条件:2~8℃,干燥,密封

    简介:AGI-6780isasmallmoleculeinhibitorofthetumorassociatedmutantIDH2(IsocitrateDehydrogenase-2)inleukemiacells.

    展开

    代谢1432660-47-3
    阿拉丁 N-环丙基-4-(3-噻吩基)-3-[[[[3-(三氟甲... AGI-6780 现货

     720.90
    A421598 10mMinDMSO
温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算
微信 ×

打开微信,点击底部的“发现”

使用“扫一扫”即可将网页分享至朋友圈